U-Blot® Research Grade Anti-Human CD66c/CEACAM6 (L-DOS-47)Cat. No. WA1756Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade Anti-Human CD66c/CEACAM6 (L-DOS-47)Cat. No. WA1756
U-Blot® Research Grade Anti-Human CD66a/CEACAM1 Antibody (MK-6018)Cat. No. WA1755
U-Blot® Research Grade Anti-Human CD66a/CEACAM1 (CM-24)Cat. No. WA1754
U-Blot® Research Grade Anti-Human CD55 (PAT SC1)Cat. No. WA1753
U-Blot® Research Grade Anti-Human CD54/ICAM1 (MSH-TP15e)Cat. No. WA1752
U-Blot® Research Grade Anti-Human CD52 (ALLO-647)Cat. No. WA1751
U-Blot® Research Grade Anti-Human CD50/ICAM3 (ICM3)Cat. No. WA1750
U-Blot® Research Grade Anti-Human CD5 (MT 101)Cat. No. WA1749
U-Blot® Research Grade Anti-Human CD5 (MAT 304)Cat. No. WA1748
U-Blot® Research Grade Anti-Human CD49a/ITGA1/VLA-1 (SAN-300)Cat. No. WA1747
U-Blot® Research Grade Anti-Human CD48 (SGN-CD48A)Cat. No. WA1746
U-Blot® Research Grade Anti-Human CD47/MER6 Antibody (CC-90002)Cat. No. WA1745